One Stop Shop for All Your Market Research Reports

Global Herpes Treatment Market 2019 Industry Research Report

Genital herpes is a common sexually transmitted disease. With the increase in population of various regions, there is also an increase in the rate of health issues around the world. As the rate of diseases grow, the treatment markets are also expected to grow substantially. With respect to sexually transmitted disease like genital herpes, its treatment market includes different drug types like Acyclovir, Valacyclovir and Famciclovir. The indication of genital herpes include HSV-1 and HSV-2.? The rising prevalence of shingles or herpes zoster in the older population is one of the key drivers responsible for the market?s growth. According to the center for disease control and prevention (CDC), almost one in every three individuals in the US are likely to develop shingles during their lifetime. People aged 50 years and above can develop this disease due to weakened immune system. Complications associated with this disease such as post-herpetic neuralgia (PHN) can cause severe pain in the areas where the rashes occurred due to shingles. People administered with immunosuppressants in the past can also develop the disease. CDC recommends that one dose of the zoster vaccine must be prescribed to adults who are 60 years and above to reduce the probability of the disease and PHN. This will drive the demand for drugs for virus types such as herpes simplex and herpes zoster, subsequently fueling market growth. One of the key trends that will stimulate growth in the global herpes treatment market in the coming years is the emergence of novel therapies. GEN-003 vaccine, developed by Genocea is under clinical trials and is effective in controlling both the shedding and outbreak of herpes simplex virus or HSV-2 infection. Shingrix vaccine developed for the treatment of herpes zoster or shingles is also expected to change the market landscape once launched in the forthcoming years. The global Herpes Treatment market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Herpes Treatment market based on company, product type, end user and key regions. This report studies the global market size of Herpes Treatment in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Herpes Treatment in these regions. This research report categorizes the global Herpes Treatment market by top players/brands, region, type and end user. This report also studies the global Herpes Treatment market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors. The following manufacturers are covered in this report, with sales, revenue, market share for each company: Gilead GlaxoSmithKline Merck Novartis Abbott Mylan Teva Pharmaceutical Industries Vical Market size by Product Acyclovir Valacyclovir Famciclovir Market size by End User Hospital Pharmacies Retail Pharmacies Online Pharmacies Drug Stores Market size by Region North America United States Canada Mexico Asia-Pacific China India Japan South Korea Australia Indonesia Singapore Malaysia Philippines Thailand Vietnam Europe Germany France UK Italy Spain Russia Central & South America Brazil Rest of Central & South America Middle East & Africa GCC Countries Turkey Egypt South Africa The study objectives of this report are: To study and analyze the global Herpes Treatment market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025. To understand the structure of Herpes Treatment market by identifying its various subsegments. To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks). Focuses on the key global Herpes Treatment companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development. To project the value and sales volume of Herpes Treatment submarkets, with respect to key regions. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market. In this study, the years considered to estimate the market size of Herpes Treatment are as follows: History Year: 2014-2018 Base Year: 2018 Estimated Year: 2019 Forecast Year 2019 to 2025 This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Herpes Treatment market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources. For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents 1 Study Coverage 1.1 Herpes Treatment Product 1.2 Market Segments 1.3 Key Manufacturers Covered 1.4 Market by Type 1.4.1 Global Herpes Treatment Market Size Growth Rate by Product 1.4.2 Acyclovir 1.4.3 Valacyclovir 1.4.4 Famciclovir 1.5 Market by End User 1.5.1 Global Herpes Treatment Market Size Growth Rat
Inquiry Before Buying

Request Sample

Share This Report

Our Clients

Payment Mode
Single User US $ 3900
Multi User US $5850
Corporate User US $7800
About this Report
Report ID 419066
Category
  • Pharmaceuticals and Healthcare
Published on 06-Jun
Number of Pages 118
Publisher Name QY Research
Editor Rating
★★★★★
★★★★★
(19)